Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 392.40
-3.45 (-0.87%)
At close: Dec 5, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €99.34 billion as of December 5, 2025. Its market cap has decreased by -12.70% in one year.
Market Cap
99.34B
Enterprise Value
90.59B
Revenue
9.99B
Ranking
n/a
PE Ratio
31.71
Stock Price
€392.40
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 99.34B, an increase of 134,353.39%. That is a compound annual growth rate of 23.30%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.76B |
| Siemens Healthineers AG | 47.61B |
| Bayer Aktiengesellschaft | 33.55B |
| Fresenius SE & Co. KGaA | 26.39B |
| Sartorius Aktiengesellschaft | 15.28B |
| Fresenius Medical Care AG | 11.73B |
| Carl Zeiss Meditec AG | 3.76B |
| Fielmann Group AG | 3.61B |